NOMIFENSINE - EFFECT IN PARKINSONIAN-PATIENTS NOT RECEIVING LEVODOPA

被引：21
|
作者：
PARK, DM [1 ]
FINDLEY, LJ [1 ]
HANKS, G [1 ]
SANDLER, M [1 ]
机构：
[1] CHARING CROSS HOSP,DEPT NEUROL,LONDON W6 8RF,ENGLAND
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 1981年 / 44卷 / 04期
关键词：
D O I：
10.1136/jnnp.44.4.352
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：352 / 354
页数：3
相关论文
共 50 条
  • [21] INCREASE IN REM-SLEEP OCULAR ACTIVITY IN PARKINSONIAN-PATIENTS TREATED WITH LEVODOPA
    LAVIE, P
    BENTAL, E
    GOSHEN, H
    SHARF, B
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1979, 15 (03): : 292 - 292
  • [22] PERIPHERAL PHARMACOKINETIC PARAMETERS OF LEVODOPA CARBIDOPA AND THE ON-OFF PHENOMENON IN PARKINSONIAN-PATIENTS
    RAINERO, I
    GILLI, M
    DEGENNARO, T
    CHIADO, I
    DELSEDIME, M
    RICCIO, A
    BERGAMASCO, B
    ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1988, 9 (03): : 225 - 259
  • [23] RESPONSE TO A STANDARD ORAL LEVODOPA TEST IN PARKINSONIAN-PATIENTS WITH AND WITHOUT MOTOR FLUCTUATIONS
    CONTIN, M
    RIVA, R
    MARTINELLI, P
    PROCACCIANTI, G
    CORTELLI, P
    AVONI, P
    BARUZZI, A
    CLINICAL NEUROPHARMACOLOGY, 1990, 13 (01) : 19 - 28
  • [24] THE EFFECT OF DEPRENYL (SELEGILINE) ON COGNITION AND EMOTION IN PARKINSONIAN-PATIENTS UNDERGOING LONG-TERM LEVODOPA TREATMENT
    PORTIN, R
    RINNE, UK
    ACTA NEUROLOGICA SCANDINAVICA, 1983, 68 : 135 - 144
  • [25] DREAM-RECALL AND DREAM CONTENT IN LEVODOPA-TREATED PARKINSONIAN-PATIENTS
    MASSETANI, R
    LUCCHETTI, R
    PICCINI, P
    BIANCHI, F
    MAESTRINI, M
    MURATORIO, A
    RESEARCH COMMUNICATIONS IN PSYCHOLOGY PSYCHIATRY AND BEHAVIOR, 1986, 11 (2-3): : 65 - 73
  • [26] CONTINUOUS SUBCUTANEOUS APOMORPHINE AS REPLACEMENT FOR LEVODOPA IN SEVERE PARKINSONIAN-PATIENTS AFTER SURGERY
    BROUSSOLLE, E
    MARION, MH
    POLLAK, P
    LANCET, 1992, 340 (8823): : 859 - 860
  • [27] INITIATION OF LEVODOPA THERAPY IN PARKINSONIAN-PATIENTS SHOULD BE DELAYED UNTIL THE ADVANCED STAGES OF THE DISEASE
    MELAMED, E
    ARCHIVES OF NEUROLOGY, 1986, 43 (04) : 402 - 405
  • [28] BIOAVAILABILITY AND ACCEPTABILITY OF A DISPERSIBLE FORMULATION OF LEVODOPA-BENSERAZIDE IN PARKINSONIAN-PATIENTS WITH AND WITHOUT DYSPHAGIA
    BAYER, AJ
    DAY, JJ
    FINUCANE, P
    PATHY, MSJ
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1988, 13 (03) : 191 - 194
  • [29] EVOLUTION OF SPEECH DISORDERS IN PARKINSONIAN-PATIENTS PRESENTING LONG-TERM LEVODOPA SYNDROMES
    BORROMEI, A
    PHARMACOLOGY, 1982, 24 (02) : 136 - 137
  • [30] DECREASED EFFICACY OF LEVODOPA WITH CARBIDOPA IN PARKINSONIAN-PATIENTS AFTER ADRENAL-TO-CAUDATE IMPLANTS
    TSUI, JKC
    PEPPARD, RF
    PETRUK, KC
    ALLEN, G
    BURNS, RS
    CALNE, DB
    NEUROLOGY, 1990, 40 (05) : 845 - 846
12345